Remove IP Remove Litigation Remove Marketing Remove Settlement
article thumbnail

Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar

LexBlog IP

announced it has signed a settlement agreement with Bayer Inc. The settlement resolves multiple patent infringement proceedings in the Federal Court of Canada. patent litigation related to biosimilars of EYLEA (aflibercept) can be found on the Big Molecule Watch’s BPCIA Litigation Tracker. Extensive cover of U.S.

article thumbnail

Litigation as a Source of Profit? Non-Practicing Entities and Patent Litigation

IPilogue

Litigation is almost always recommended to be avoided , whether because of the sheer amount of time needed to get a court date, the expensive costs for the client and law firm, or the risks associated with receiving an unfavorable judgement. Michelle Mao is an incoming 2L JD student at Osgoode Hall Law school and an IPilogue Writer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Under the Bridge | The Rise of Copyright Trolls in the Intellectual Property Space

JD Supra Law

Through tactical litigation practices, copyright trolls rely on copyright law to allege infringement and threaten major statutory damages upon unsuspecting defendants.

article thumbnail

Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation

LexBlog IP

The post Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation appeared first on Big Molecule Watch.

article thumbnail

Attys Get $18.8M In Allergan, Merz 'Pay-For-Delay' Settlement

IP Law 360

Plaintiffs counsel in a class action from consumers who alleged Allergan and Merz delayed generic versions of Alzheimer's drugs from coming to market will be awarded 33.3%, plus litigation expense reimbursement, of an eight-figure settlement.

article thumbnail

My New Article on Abusive “Schedule A” IP Lawsuits Will Likely Leave You Angry

Technology & Marketing Law Blog

I’m pleased to share a draft of a new paper, “ A SAD New Category of Abusive Intellectual Property Litigation.” The SAD Scheme capitalizes on weak spots in the Federal Rules of Civil Procedure, judicial deference to IP rightsowners, and online marketplaces’ desire to reduce their liability exposure.

IP 103
article thumbnail

Georgia Supreme Court Blesses Google’s Keyword Ad Sales–Edible IP v. Google

Technology & Marketing Law Blog

Even though this is an obviously stupid legal theory that wasn’t worth anyone’s time or money, Edible turned to an Atlanta litigation boutique (shoutout to Bondurant Mixson & Elmore LLP!!!) I have a long-standing personal policy not to give my consumer dollars to any entity that I mock on the blog for IP overreaches.

IP 127